MedPath

Lidocaine and Prilocaine

Lidocaine 2.5% and Prilocaine 2.5% Cream, USP

Approved
Approval ID

1972d657-2d5a-4697-bba9-80caffc2f2d7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 31, 2019

Manufacturers
FDA

Actavis Pharma, Inc.

DUNS: 119723554

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lidocaine and prilocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0591-2070
Application NumberNDA019941
Product Classification
M
Marketing Category
C73605
G
Generic Name
lidocaine and prilocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 31, 2019
FDA Product Classification

INGREDIENTS (6)

LIDOCAINEActive
Quantity: 25 mg in 1 g
Code: 98PI200987
Classification: ACTIB
PRILOCAINEActive
Quantity: 25 mg in 1 g
Code: 046O35D44R
Classification: ACTIB
CARBOMER 934Inactive
Code: Z135WT9208
Classification: IACT
PEG-55 HYDROGENATED CASTOR OILInactive
Code: 0WZF1506N9
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine and Prilocaine - FDA Drug Approval Details